Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Work In Process (2019 - 2025)

Pulmonx (LUNG) has disclosed Work In Process for 7 consecutive years, with $577000.0 as the latest value for Q3 2025.

  • Quarterly Work In Process rose 56.37% to $577000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $577000.0 through Sep 2025, up 56.37% year-over-year, with the annual reading at $457000.0 for FY2024, 7.03% up from the prior year.
  • Work In Process for Q3 2025 was $577000.0 at Pulmonx, up from $562000.0 in the prior quarter.
  • The five-year high for Work In Process was $784000.0 in Q2 2022, with the low at $313000.0 in Q1 2021.
  • Average Work In Process over 5 years is $513842.1, with a median of $503000.0 recorded in 2025.
  • The sharpest move saw Work In Process surged 139.62% in 2022, then tumbled 39.15% in 2024.
  • Over 5 years, Work In Process stood at $518000.0 in 2021, then dropped by 25.48% to $386000.0 in 2022, then grew by 10.62% to $427000.0 in 2023, then grew by 7.03% to $457000.0 in 2024, then increased by 26.26% to $577000.0 in 2025.
  • According to Business Quant data, Work In Process over the past three periods came in at $577000.0, $562000.0, and $503000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.